載入...

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

BACKGROUND: The degree of glycemic control in patients with type 2 diabetes mellitus (T2DM) may alter lipid levels and may alter the efficacy of lipid-modifying agents. OBJECTIVE: Evaluate the lipid-modifying efficacy of extended-release niacin/laropiprant (ERN/LRPT) in subgroups of patients with T2...

全面介紹

Na minha lista:
書目詳細資料
發表在:Vasc Health Risk Manag
Main Authors: Bays, Harold E, Brinton, Eliot A, Triscari, Joseph, Chen, Erluo, Maccubbin, Darbie, MacLean, Alexandra A, Gibson, Kendra L, Ruck, Rae Ann, Johnson-Levonas, Amy O, O’Neill, Edward A, Mitchel, Yale B
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4348131/
https://ncbi.nlm.nih.gov/pubmed/25750540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S70907
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!